KalVista Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: KalVista Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: KalVista Pharmaceuticals Inc
Rating: 1.50716675
Author: Trendlyne DVM scores

about

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discove...

16.02 -0.52 (-3.14%)

90.71% Gain from 52W Low

487.5K

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

0.7 / 100

Technically Neutral

59.6 / 100

No estimates available

KalVista Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

KalVista Pharma Inc Live Stock Price Today, Share Analysis and Chart

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discove...

90.71% Gain from 52W Low

SWOT Analysis

KalVista Pharma Inc Live Price Chart